Onderneming Cerevel Therapeutics Holdings, Inc.
Aandelen
CERE
US15678U1280
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
40,63 USD | -0,27% | -1,69% | -4,17% |
Vakgebied
Aantal werknemers: 355
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12-06-23 |
Director of Finance/CFO | 42 | 15-05-23 | |
N. Coles
CHM | Chairman | 63 | 01-12-18 |
Raymond Sanchez
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-01-19 |
John Renger
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-05-19 |
53 | - | ||
Matthew Calistri
IRC | Investor Relations Contact | - | - |
Scott Akamine
LAW | General Counsel | 40 | 24-05-21 |
Mark Bodenrader
AUD | Comptroller/Controller/Auditor | 51 | 01-09-19 |
Paul Burgess
PRN | Corporate Officer/Principal | 50 | 20-06-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-06-19 | |
Douglas Giordano
BRD | Director/Board Member | 61 | 01-09-18 |
Ruth McKernan
BRD | Director/Board Member | 66 | 04-12-20 |
Deval Patrick
BRD | Director/Board Member | 67 | 20-01-21 |
Marijn Dekkers
BRD | Director/Board Member | 65 | 01-09-18 |
Norbert Riedel
BRD | Director/Board Member | 66 | 01-12-18 |
N. Coles
CHM | Chairman | 63 | 01-12-18 |
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12-06-23 |
Director/Board Member | 51 | 01-09-18 | |
Suneet Varma
BRD | Director/Board Member | 55 | 14-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 182 194 722 | 77 490 691 ( 42,53 %) | 0 | 42,53 % |
Bedrijfsgegevens
Cerevel Therapeutics Holdings, Inc.
222 Jacobs Street Suite 200
02141, Cambridge
+844 304 2048
http://www.cerevel.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,17% | 7,4 mld. | |
+15,55% | 121 mld. | |
+12,66% | 107 mld. | |
-2,53% | 24,82 mld. | |
+1,14% | 22,48 mld. | |
-9,35% | 18,32 mld. | |
-42,28% | 16,33 mld. | |
-18,92% | 15,31 mld. | |
+6,19% | 14,08 mld. | |
+28,83% | 11,74 mld. |
- Beurs
- Aandelen
- Koers CERE
- Onderneming Cerevel Therapeutics Holdings, Inc.